{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T15:26:08Z","timestamp":1763911568759,"version":"3.40.3"},"publisher-location":"Cham","reference-count":111,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783031297496"},{"type":"electronic","value":"9783031297502"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-3-031-29750-2_10","type":"book-chapter","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T09:02:51Z","timestamp":1689066171000},"page":"121-135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Advances in Central Nervous System Tumor Classification"],"prefix":"10.1007","author":[{"given":"Tathiane M.","family":"Malta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houtan","family":"Noushmehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Valeria","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"issue":"5","key":"10_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/neuonc\/nov316","volume":"18","author":"M Abedalthagafi","year":"2016","unstructured":"Abedalthagafi, M., Bi, W.L., Aizer, A.A., et al. 2016. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro-oncology 18(5), pp. 649\u2013655.","journal-title":"Neuro-oncology"},{"key":"10_CR2","doi-asserted-by":"crossref","unstructured":"Adeberg, S., Hartmann, C., Welzel, T., et al. 2012. Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy. International Journal of Radiation Oncology, Biology, Physics 83(3), pp. 859\u2013864.","DOI":"10.1016\/j.ijrobp.2011.08.010"},{"issue":"10","key":"10_CR3","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2342::AID-CNCR19>3.0.CO;2-X","volume":"88","author":"K Aldape","year":"2000","unstructured":"Aldape, K., Simmons, M.L., Davis, R.L., et al. 2000. Discrepancies in diagnoses of neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma Study. Cancer 88(10), pp. 2342\u20132349.","journal-title":"Cancer"},{"key":"10_CR4","doi-asserted-by":"crossref","unstructured":"Balik, V., Kourilova, P., Sulla, I., et al. 2020. Recurrence of surgically treated parasagittal meningiomas: a meta-analysis of risk factors. Acta Neurochirurgica.","DOI":"10.1007\/s00701-020-04336-3"},{"issue":"1","key":"10_CR5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1186\/s12885-020-06982-3","volume":"20","author":"A-M Barciszewska","year":"2020","unstructured":"Barciszewska, A.-M. 2020. Total DNA methylation as a biomarker of DNA damage and tumor malignancy in intracranial meningiomas. BMC Cancer 20(1), p. 509.","journal-title":"BMC Cancer"},{"issue":"3","key":"10_CR6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00401-016-1598-1","volume":"132","author":"P Baumgarten","year":"2016","unstructured":"Baumgarten, P., Gessler, F., Schittenhelm, J., et al. 2016. Brain invasion in otherwise benign meningiomas does not predict tumor recurrence. Acta Neuropathologica 132(3), pp. 479\u2013481.","journal-title":"Acta Neuropathologica"},{"issue":"4","key":"10_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s002340000419","volume":"43","author":"M Bendszus","year":"2001","unstructured":"Bendszus, M., Warmuth-Metz, M., Burger, R., Klein, R., Tonn, J.C. and Solymosi, L. 2001. Diagnosing dural metastases: the value of 1H magnetic resonance spectroscopy. Neuroradiology 43(4), pp. 285\u2013289.","journal-title":"Neuroradiology"},{"issue":"3","key":"10_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00401-010-0725-7","volume":"120","author":"MJ van den Bent","year":"2010","unstructured":"van den Bent, M.J. 2010. Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician\u2019s perspective. Acta Neuropathologica 120(3), pp. 297\u2013304.","journal-title":"Acta Neuropathologica"},{"key":"10_CR9","doi-asserted-by":"crossref","unstructured":"Bi, W.L., Greenwald, N.F., Abedalthagafi, M., et al. 2017a. Genomic landscape of high-grade meningiomas. NPJ genomic medicine 2.","DOI":"10.1038\/s41525-017-0014-7"},{"issue":"7","key":"10_CR10","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1158\/1078-0432.CCR-16-0790","volume":"23","author":"WL Bi","year":"2017","unstructured":"Bi, W.L., Horowitz, P., Greenwald, N.F., et al. 2017b. Landscape of genomic alterations in pituitary adenomas. Clinical Cancer Research 23(7), pp. 1841\u20131851.","journal-title":"Clinical Cancer Research"},{"issue":"2","key":"10_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.nec.2015.11.009","volume":"27","author":"WL Bi","year":"2016","unstructured":"Bi, W.L., Mei, Y., Agarwalla, P.K., Beroukhim, R. and Dunn, I.F. 2016a. Genomic and epigenomic landscape in meningioma. Neurosurgery clinics of North America 27(2), pp. 167\u2013179.","journal-title":"Neurosurgery clinics of North America"},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fsurg.2016.00040","volume":"3","author":"WL Bi","year":"2016","unstructured":"Bi, W.L., Zhang, M., Wu, W.W., Mei, Y. and Dunn, I.F. 2016b. Meningioma genomics: diagnostic, prognostic, and therapeutic applications. Frontiers in surgery 3, p. 40.","journal-title":"Frontiers in surgery"},{"issue":"6","key":"10_CR13","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1007\/s00261-019-02028-w","volume":"44","author":"Z Bodalal","year":"2019","unstructured":"Bodalal, Z., Trebeschi, S., Nguyen-Kim, T.D.L., Schats, W. and Beets-Tan, R. 2019. Radiogenomics: bridging imaging and genomics. Abdominal Radiology (New York) 44(6), pp. 1960\u20131984.","journal-title":"Abdominal Radiology (New York)"},{"issue":"3","key":"10_CR14","first-page":"345","volume":"19","author":"J Boetto","year":"2017","unstructured":"Boetto, J., Bielle, F., Sanson, M., Peyre, M. and Kalamarides, M. 2017. SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas. Neuro-oncology 19(3), pp. 345\u2013351.","journal-title":"Neuro-oncology"},{"issue":"2","key":"10_CR15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1148\/radiol.2016160218","volume":"281","author":"D Bos","year":"2016","unstructured":"Bos, D., Poels, M.M.F., Adams, H.H.H., et al. 2016. Prevalence, Clinical Management, and Natural Course of Incidental Findings on Brain MR Images: The Population-based Rotterdam Scan Study. Radiology 281(2), pp. 507\u2013515.","journal-title":"Radiology"},{"issue":"10","key":"10_CR16","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1093\/neuonc\/nox071","volume":"19","author":"B Brokinkel","year":"2017","unstructured":"Brokinkel, B., Hess, K. and Mawrin, C. 2017. Brain invasion in meningiomas-clinical considerations and impact of neuropathological evaluation: a systematic review. Neuro-oncology 19(10), pp. 1298\u20131307.","journal-title":"Neuro-oncology"},{"issue":"9","key":"10_CR17","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s00701-018-3593-x","volume":"160","author":"KP Budohoski","year":"2018","unstructured":"Budohoski, K.P., Clerkin, J., Millward, C.P., et al. 2018. Predictors of early progression of surgically treated atypical meningiomas. Acta Neurochirurgica 160(9), pp. 1813\u20131822.","journal-title":"Acta Neurochirurgica"},{"issue":"26","key":"10_CR18","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","volume":"372","author":"DJ Brat","year":"2015","unstructured":"Cancer Genome Atlas Research Network, Brat, D.J., Verhaak, R.G.W., et al. 2015. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. The New England Journal of Medicine 372(26), pp. 2481\u20132498.","journal-title":"The New England Journal of Medicine"},{"issue":"7697","key":"10_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper, D., Jones, D.T.W., Sill, M., et al. 2018a. DNA methylation-based classification of central nervous system tumours. Nature 555(7697), pp. 469\u2013474.","journal-title":"Nature"},{"issue":"2","key":"10_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00401-018-1879-y","volume":"136","author":"D Capper","year":"2018","unstructured":"Capper, D., Stichel, D., Sahm, F., et al. 2018b. Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathologica 136(2), pp. 181\u2013210.","journal-title":"Acta Neuropathologica"},{"key":"10_CR21","doi-asserted-by":"crossref","unstructured":"Cardona, A.F., Ruiz-Pati\u00f1o, A., Zatarain-Barr\u00f3n, Z.L., et al. 2019. Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib. Plos One 14(6), p. e0217340.","DOI":"10.1371\/journal.pone.0217340"},{"issue":"3","key":"10_CR22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.cell.2015.12.028","volume":"164","author":"M Ceccarelli","year":"2016","unstructured":"Ceccarelli, M., Barthel, F.P., Malta, T.M., et al. 2016. Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 164(3), pp. 550\u2013563.","journal-title":"Cell"},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.3389\/fonc.2019.01338","volume":"9","author":"C Chen","year":"2019","unstructured":"Chen, C., Guo, X., Wang, J., Guo, W., Ma, X. and Xu, J. 2019. The Diagnostic Value of Radiomics-Based Machine Learning in Predicting the Grade of Meningiomas Using Conventional Magnetic Resonance Imaging: A Preliminary Study. Frontiers in oncology 9, p. 1338.","journal-title":"Frontiers in oncology"},{"issue":"6123","key":"10_CR24","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","volume":"339","author":"VE Clark","year":"2013","unstructured":"Clark, V.E., Erson-Omay, E.Z., Serin, A., et al. 2013. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339(6123), pp. 1077\u20131080.","journal-title":"Science"},{"issue":"10","key":"10_CR25","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/ng.3651","volume":"48","author":"VE Clark","year":"2016","unstructured":"Clark, V.E., Harmanc\u0131, A.S., Bai, H., et al. 2016. Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas. Nature Genetics 48(10), pp. 1253\u20131259.","journal-title":"Nature Genetics"},{"key":"10_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jocn.2019.05.063","volume":"67","author":"O Cohen-Inbar","year":"2019","unstructured":"Cohen-Inbar, O. 2019. Geriatric brain tumor management part I: Meningioma. Journal of Clinical Neuroscience 67, pp. 5\u20139.","journal-title":"Journal of Clinical Neuroscience"},{"issue":"1","key":"10_CR27","doi-asserted-by":"publisher","first-page":"13537","DOI":"10.1038\/s41598-018-31659-0","volume":"8","author":"G Collord","year":"2018","unstructured":"Collord, G., Tarpey, P., Kurbatova, N., et al. 2018. An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures. Scientific Reports 8(1), p. 13537.","journal-title":"Scientific Reports"},{"issue":"8","key":"10_CR28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s11912-020-00937-4","volume":"22","author":"C Cordova","year":"2020","unstructured":"Cordova, C. and Kurz, S.C. 2020. Advances in molecular classification and therapeutic opportunities in meningiomas. Current Oncology Reports 22(8), p. 84.","journal-title":"Current Oncology Reports"},{"issue":"5","key":"10_CR29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/neuonc\/not325","volume":"16","author":"PH Domingues","year":"2014","unstructured":"Domingues, P.H., Sousa, P., Otero, \u00c1., et al. 2014. Proposal for a new risk stratification classification for meningioma based on patient age, WHO tumor grade, size, localization, and karyotype. Neuro-oncology 16(5), pp. 735\u2013747.","journal-title":"Neuro-oncology"},{"issue":"19","key":"10_CR30","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM200011093431901","volume":"343","author":"M Esteller","year":"2000","unstructured":"Esteller, M., Garcia-Foncillas, J., Andion, E., et al. 2000. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. The New England Journal of Medicine 343(19), pp. 1350\u20131354.","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"10_CR31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11060-018-2891-8","volume":"139","author":"RG Everson","year":"2018","unstructured":"Everson, R.G., Hashimoto, Y., Freeman, J.L., et al. 2018. Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design. Journal of Neuro-Oncology 139(2), pp. 469\u2013478.","journal-title":"Journal of Neuro-Oncology"},{"key":"10_CR32","doi-asserted-by":"crossref","unstructured":"Gallo Cantafio, M.E., Grillone, K., Caracciolo, D., et al. 2018. From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology. High-Throughput 7(4).","DOI":"10.3390\/ht7040033"},{"key":"10_CR33","doi-asserted-by":"crossref","unstructured":"Gao, F., Shi, L., Russin, J., et al. 2013. DNA methylation in the malignant transformation of meningiomas. Plos One 8(1), p. e54114.","DOI":"10.1371\/journal.pone.0054114"},{"key":"10_CR34","doi-asserted-by":"crossref","unstructured":"Gilles, F.H., Tavar\u00e9, C.J., Becker, L.E., et al. 2008. Pathologist interobserver variability of histologic features in childhood brain tumors: results from the CCG-945 study. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 11(2), pp. 108\u2013117.","DOI":"10.2350\/07-06-0303.1"},{"key":"10_CR35","doi-asserted-by":"crossref","unstructured":"Goldbrunner, R., Minniti, G., Preusser, M., et al. 2016. EANO guidelines for the diagnosis and treatment of meningiomas. The Lancet Oncology 17(9), pp. e383-91.","DOI":"10.1016\/S1470-2045(16)30321-7"},{"issue":"3","key":"10_CR36","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3171\/2015.9.JNS15754","volume":"125","author":"K Gousias","year":"2016","unstructured":"Gousias, K., Schramm, J. and Simon, M. 2016. The Simpson grading revisited: aggressive surgery and its place in modern meningioma management. Journal of Neurosurgery 125(3), pp. 551\u2013560.","journal-title":"Journal of Neurosurgery"},{"key":"10_CR37","doi-asserted-by":"publisher","first-page":"14433","DOI":"10.1038\/ncomms14433","volume":"8","author":"AS Harmanc\u0131","year":"2017","unstructured":"Harmanc\u0131, A.S., Youngblood, M.W., Clark, V.E., et al. 2017. Integrated genomic analyses of de novo pathways underlying atypical meningiomas. Nature Communications 8, p. 14433.","journal-title":"Nature Communications"},{"issue":"Suppl 1","key":"10_CR38","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.21037\/cco.2017.05.02","volume":"6","author":"PN Harter","year":"2017","unstructured":"Harter, P.N., Braun, Y. and Plate, K.H. 2017. Classification of meningiomas-advances and controversies. Chinese clinical oncology 6(Suppl 1), p. S2.","journal-title":"Chinese clinical oncology"},{"issue":"6","key":"10_CR39","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/neuonc\/nov285","volume":"18","author":"WL Hwang","year":"2016","unstructured":"Hwang, W.L., Marciscano, A.E., Niemierko, A., et al. 2016. Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade. Neuro-oncology 18(6), pp. 863\u2013872.","journal-title":"Neuro-oncology"},{"issue":"3","key":"10_CR40","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1055\/s-2007-970554","volume":"17","author":"F Ildan","year":"2007","unstructured":"Ildan, F., Erman, T., G\u00f6\u00e7er, A.I., et al. 2007. Predicting the probability of meningioma recurrence in the preoperative and early postoperative period: a multivariate analysis in the midterm follow-up. Skull Base 17(3), pp. 157\u2013171.","journal-title":"Skull Base"},{"key":"10_CR41","doi-asserted-by":"publisher","first-page":"e725","DOI":"10.1016\/j.wneu.2020.03.060","volume":"138","author":"AI Islim","year":"2020","unstructured":"Islim, A.I., Mohan, M., Moon, R.D.C., et al. 2020. Treatment Outcomes of Incidental Intracranial Meningiomas: Results from the IMPACT Cohort. World neurosurgery 138, pp. e725\u2013e735.","journal-title":"World neurosurgery"},{"key":"10_CR42","doi-asserted-by":"crossref","unstructured":"J\u00e4\u00e4skel\u00e4inen, J. 1986. Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surgical Neurology 26(5), pp. 461\u2013469.","DOI":"10.1016\/0090-3019(86)90259-4"},{"issue":"1","key":"10_CR43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13148-019-0766-2","volume":"11","author":"S Karimi","year":"2019","unstructured":"Karimi, S., Zuccato, J.A., Mamatjan, Y., et al. 2019. The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care. Clinical epigenetics 11(1), p. 185.","journal-title":"Clinical epigenetics"},{"issue":"2","key":"10_CR44","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nec.2015.11.002","volume":"27","author":"M Karsy","year":"2016","unstructured":"Karsy, M., Guan, J., Cohen, A., Colman, H. and Jensen, R.L. 2016. Medical management of meningiomas: current status, failed treatments, and promising horizons. Neurosurgery clinics of North America 27(2), pp. 249\u2013260.","journal-title":"Neurosurgery clinics of North America"},{"issue":"3","key":"10_CR45","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","volume":"124","author":"D-A Khuong-Quang","year":"2012","unstructured":"Khuong-Quang, D.-A., Buczkowicz, P., Rakopoulos, P., et al. 2012. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathologica 124(3), pp. 439\u2013447.","journal-title":"Acta Neuropathologica"},{"issue":"2","key":"10_CR46","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/carcin\/bgr260","volume":"33","author":"Y Kishida","year":"2012","unstructured":"Kishida, Y., Natsume, A., Kondo, Y., et al. 2012. Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses. Carcinogenesis 33(2), pp. 436\u2013441.","journal-title":"Carcinogenesis"},{"issue":"8","key":"10_CR47","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/annonc\/mdz164","volume":"30","author":"BW Kristensen","year":"2019","unstructured":"Kristensen, B.W., Priesterbach-Ackley, L.P., Petersen, J.K. and Wesseling, P. 2019. Molecular pathology of tumors of the central nervous system. Annals of Oncology 30(8), pp. 1265\u20131278.","journal-title":"Annals of Oncology"},{"key":"10_CR48","doi-asserted-by":"crossref","unstructured":"Lee, Young Suk and Lee, Youn Soo 2020. Molecular characteristics of meningiomas. Journal of pathology and translational medicine 54(1), pp. 45\u201363.","DOI":"10.4132\/jptm.2019.11.05"},{"issue":"13","key":"10_CR49","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1038\/sj.onc.1202531","volume":"18","author":"PE Leone","year":"1999","unstructured":"Leone, P.E., Bello, M.J., de Campos, J.M., et al. 1999. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas. Oncogene 18(13), pp. 2231\u20132239.","journal-title":"Oncogene"},{"issue":"1","key":"10_CR50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13046-018-0893-1","volume":"37","author":"J Li","year":"2018","unstructured":"Li, J., Han, X., Yu, X., et al. 2018b. Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Journal of Experimental & Clinical Cancer Research 37(1), p. 213.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"9","key":"10_CR51","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1007\/s00330-017-5302-1","volume":"28","author":"Z-C Li","year":"2018","unstructured":"Li, Z.-C., Bai, H., Sun, Q., et al. 2018a. Multiregional radiomics features from multiparametric MRI for prediction of MGMT methylation status in glioblastoma multiforme: A multicentre study. European Radiology 28(9), pp. 3640\u20133650.","journal-title":"European Radiology"},{"key":"10_CR52","doi-asserted-by":"publisher","unstructured":"Louis, D.N., Perry, A., Wesseling, P., Brat, D.J., Cree, I.A., Figarella-Branger, D., Hawkins. C., Ng, H.K., Pfister, S.M., Reifenberger, G., Soffietti, R., von Deimling, A., Ellison, D.W. 2021. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-oncology 23(8), pp. 1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106. PMID: 34185076; PMCID: PMC8328013.","DOI":"10.1093\/neuonc\/noab106"},{"issue":"1","key":"10_CR53","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3171\/2015.1.JNS142228","volume":"124","author":"AE Marciscano","year":"2016","unstructured":"Marciscano, A.E., Stemmer-Rachamimov, A.O., Niemierko, A., et al. 2016. Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes. Journal of Neurosurgery 124(1), pp. 106\u2013114.","journal-title":"Journal of Neurosurgery"},{"issue":"12","key":"10_CR54","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1158\/1078-0432.CCR-17-3800","volume":"24","author":"F Mart\u00ednez-Ricarte","year":"2018","unstructured":"Mart\u00ednez-Ricarte, F., Mayor, R., Mart\u00ednez-S\u00e1ez, E., et al. 2018. Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid. Clinical Cancer Research 24(12), pp. 2812\u20132819.","journal-title":"Clinical Cancer Research"},{"key":"10_CR55","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/B978-0-12-802997-8.00006-2","volume":"134","author":"K Masui","year":"2016","unstructured":"Masui, K., Mischel, P.S. and Reifenberger, G. 2016. Molecular classification of gliomas. Handbook of Clinical Neurology 134, pp. 97\u2013120.","journal-title":"Handbook of Clinical Neurology"},{"key":"10_CR56","doi-asserted-by":"crossref","unstructured":"Mawrin, C., Chung, C. and Preusser, M. 2015. Biology and clinical management challenges in meningioma. American Society of Clinical Oncology educational book\/ASCO. American Society of Clinical Oncology. Meeting, pp. e106-15.","DOI":"10.14694\/EdBook_AM.2015.35.e106"},{"issue":"6","key":"10_CR57","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3171\/jns.1996.85.6.1091","volume":"85","author":"MA Mittler","year":"1996","unstructured":"Mittler, M.A., Walters, B.C. and Stopa, E.G. 1996. Observer reliability in histological grading of astrocytoma stereotactic biopsies. Journal of Neurosurgery 85(6), pp. 1091\u20131094.","journal-title":"Journal of Neurosurgery"},{"key":"10_CR58","doi-asserted-by":"crossref","unstructured":"Morin, O., Chen, W.C., Nassiri, F., et al. 2019. Integrated models incorporating radiologic and radiomic features predict meningioma grade, local failure, and overall survival. Neuro-Oncology Advances 1(1), p. vdz011.","DOI":"10.1093\/noajnl\/vdz011"},{"key":"10_CR59","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.25.061903","volume-title":"DNA Methylation-based Signatures Classify Sporadic Pituitary Tumors According to Clinicopathological Features","author":"MS Mosella","year":"2020","unstructured":"Mosella, M.S., Sabedot, T.S., Silva, T.C., et al. 2020. DNA Methylation-based Signatures Classify Sporadic Pituitary Tumors According to Clinicopathological Features. BioRxiv."},{"key":"10_CR60","doi-asserted-by":"crossref","unstructured":"Mouliere, F., Mair, R., Chandrananda, D., et al. 2018. Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients. EMBO Molecular Medicine 10(12).","DOI":"10.15252\/emmm.201809323"},{"key":"10_CR61","doi-asserted-by":"crossref","unstructured":"Murny\u00e1k, B., Bogn\u00e1r, L., Klekner, \u00c1. and Hortob\u00e1gyi, T. 2015. Epigenetics of Meningiomas. BioMed research international 2015, p. 532451.","DOI":"10.1155\/2015\/532451"},{"issue":"7","key":"10_CR62","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/neuonc\/noz061","volume":"21","author":"F Nassiri","year":"2019","unstructured":"Nassiri, F., Mamatjan, Y., Suppiah, S., et al. 2019. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro-oncology 21(7), pp. 901\u2013910.","journal-title":"Neuro-oncology"},{"key":"10_CR63","doi-asserted-by":"crossref","unstructured":"Neou, M., Villa, C., Armignacco, R., et al. 2019. Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell.","DOI":"10.1530\/endoabs.63.GP243"},{"key":"10_CR64","doi-asserted-by":"crossref","unstructured":"Noushmehr, H., Sabedot, T.S., Malta, T.M., et al. 2019. Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers. BioRxiv.","DOI":"10.1101\/601245"},{"issue":"5","key":"10_CR65","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","volume":"17","author":"H Noushmehr","year":"2010","unstructured":"Noushmehr, H., Weisenberger, D.J., Diefes, K., et al. 2010. Identification of a CpG Island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17(5), pp. 510\u2013522.","journal-title":"Cancer Cell"},{"issue":"12","key":"10_CR66","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1093\/neuonc\/nox101","volume":"19","author":"M Nowosielski","year":"2017","unstructured":"Nowosielski, M., Galldiks, N., Iglseder, S., et al. 2017. Diagnostic challenges in meningioma. Neuro-oncology 19(12), pp. 1588\u20131598.","journal-title":"Neuro-oncology"},{"issue":"6","key":"10_CR67","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.pjnns.2016.08.003","volume":"50","author":"W Och","year":"2016","unstructured":"Och, W., Szmuda, T., Sikorska, B., et al. 2016. Recurrence-associated chromosomal anomalies in meningiomas: Single-institution study and a systematic review with meta-analysis. Neurologia i neurochirurgia polska 50(6), pp. 439\u2013448.","journal-title":"Neurologia i neurochirurgia polska"},{"issue":"2","key":"10_CR68","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/FTD.0000000000000566","volume":"41","author":"M Oellerich","year":"2019","unstructured":"Oellerich, M., Sch\u00fctz, E., Beck, J. and Walson, P.D. 2019. Circulating Cell-Free DNA-Diagnostic and Prognostic Applications in Personalized Cancer Therapy. Therapeutic Drug Monitoring 41(2), pp. 115\u2013120.","journal-title":"Therapeutic Drug Monitoring"},{"issue":"3","key":"10_CR69","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00401-017-1678-x","volume":"133","author":"A Olar","year":"2017","unstructured":"Olar, A., Wani, K.M., Wilson, C.D., et al. 2017. Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma. Acta Neuropathologica 133(3), pp. 431\u2013444.","journal-title":"Acta Neuropathologica"},{"key":"10_CR70","doi-asserted-by":"crossref","unstructured":"Ostrom, Q.T., Gittleman, H., Truitt, G., Boscia, A., Kruchko, C. and Barnholtz-Sloan, J.S. 2018. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015. Neuro-oncology 20(suppl_4), pp. iv1\u2013iv86.","DOI":"10.1093\/neuonc\/noy131"},{"key":"10_CR71","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.wneu.2016.09.007","volume":"96","author":"A Otero-Rodriguez","year":"2016","unstructured":"Otero-Rodriguez, A., Tabernero, M.D., Munoz-Martin, M.C., et al. 2016. Re-Evaluating Simpson Grade I, II, and III Resections in Neurosurgical Treatment of World Health Organization Grade I Meningiomas. World neurosurgery 96, pp. 483\u2013488.","journal-title":"World neurosurgery"},{"issue":"5","key":"10_CR72","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ccell.2015.04.002","volume":"27","author":"KW Pajtler","year":"2015","unstructured":"Pajtler, K.W., Witt, H., Sill, M., et al. 2015. Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups. Cancer Cell 27(5), pp. 728\u2013743.","journal-title":"Cancer Cell"},{"issue":"5","key":"10_CR73","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3171\/jns.1997.86.5.0793","volume":"86","author":"L Palma","year":"1997","unstructured":"Palma, L., Celli, P., Franco, C., Cervoni, L. and Cantore, G. 1997. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. Journal of Neurosurgery 86(5), pp. 793\u2013800.","journal-title":"Journal of Neurosurgery"},{"key":"10_CR74","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/B978-0-12-804280-9.00015-9","volume":"169","author":"MN Pamir","year":"2020","unstructured":"Pamir, M.N. and \u00d6zduman, K. 2020. Current decision-making in meningiomas. Handbook of Clinical Neurology 169, pp. 229\u2013252.","journal-title":"Handbook of Clinical Neurology"},{"issue":"23","key":"10_CR75","doi-asserted-by":"publisher","first-page":"5850","DOI":"10.1158\/1078-0432.CCR-18-1345","volume":"24","author":"E Panditharatna","year":"2018","unstructured":"Panditharatna, E., Kilburn, L.B., Aboian, M.S., et al. 2018. Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy. Clinical Cancer Research 24(23), pp. 5850\u20135859.","journal-title":"Clinical Cancer Research"},{"issue":"7489","key":"10_CR76","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature13109","volume":"506","author":"M Parker","year":"2014","unstructured":"Parker, M., Mohankumar, K.M., Punchihewa, C., et al. 2014. C11orf95-RELA fusions drive oncogenic NF-\u03baB signalling in ependymoma. Nature 506(7489), pp. 451\u2013455.","journal-title":"Nature"},{"issue":"8","key":"10_CR77","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1007\/s00330-018-5830-3","volume":"29","author":"YW Park","year":"2019","unstructured":"Park, Y.W., Oh, J., You, S.C., et al. 2019. Radiomics and machine learning may accurately predict the grade and histological subtype in meningiomas using conventional and diffusion tensor imaging. European Radiology 29(8), pp. 4068\u20134076.","journal-title":"European Radiology"},{"issue":"43","key":"10_CR78","doi-asserted-by":"publisher","first-page":"21715","DOI":"10.1073\/pnas.1912858116","volume":"116","author":"AJ Patel","year":"2019","unstructured":"Patel, A.J., Wan, Y.-W., Al-Ouran, R., et al. 2019. Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors. Proceedings of the National Academy of Sciences of the United States of America 116(43), pp. 21715\u201321726.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10_CR79","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clineuro.2018.12.004","volume":"176","author":"BJA Pereira","year":"2019","unstructured":"Pereira, B.J.A., Oba-Shinjo, S.M., de Almeida, A.N. and Marie, S.K.N. 2019. Molecular alterations in meningiomas: Literature review. Clinical Neurology and Neurosurgery 176, pp. 89\u201396.","journal-title":"Clinical Neurology and Neurosurgery"},{"key":"10_CR80","doi-asserted-by":"crossref","unstructured":"Piccioni, D.E., Achrol, A.S., Kiedrowski, L.A., et al. 2019. Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumors. CNS oncology 8(2), p. CNS34.","DOI":"10.2217\/cns-2018-0015"},{"key":"10_CR81","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.wneu.2018.08.019","volume":"119","author":"DT Proctor","year":"2018","unstructured":"Proctor, D.T., Ramachandran, S., Lama, S. and Sutherland, G.R. 2018. Towards molecular classification of meningioma: evolving treatment and diagnostic paradigms. World neurosurgery 119, pp. 366\u2013373.","journal-title":"World neurosurgery"},{"issue":"5","key":"10_CR82","first-page":"819","volume":"68","author":"A Quddusi","year":"2018","unstructured":"Quddusi, A. and Shamim, M.S. 2018. Simpson grading as predictor of meningioma recurrence. The Journal of the Pakistan Medical Association 68(5), pp. 819\u2013821.","journal-title":"The Journal of the Pakistan Medical Association"},{"issue":"1","key":"10_CR83","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s41747-018-0068-z","volume":"2","author":"S Rizzo","year":"2018","unstructured":"Rizzo, S., Botta, F., Raimondi, S., et al. 2018. Radiomics: the facts and the challenges of image analysis. European Radiology Experimental 2(1), p. 36.","journal-title":"European Radiology Experimental"},{"issue":"4","key":"10_CR84","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/neuonc\/nov247","volume":"18","author":"CL Rogers","year":"2016","unstructured":"Rogers, C.L., Perry, A., Pugh, S., et al. 2016. Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539. Neuro-oncology 18(4), pp. 565\u2013574.","journal-title":"Neuro-oncology"},{"issue":"4","key":"10_CR85","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.ijrobp.2019.11.028","volume":"106","author":"CL Rogers","year":"2020","unstructured":"Rogers, C.L., Won, M., Vogelbaum, M.A., et al. 2020. High-risk Meningioma: Initial Outcomes From NRG Oncology\/RTOG 0539. International Journal of Radiation Oncology, Biology, Physics 106(4), pp. 790\u2013799.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10_CR86","doi-asserted-by":"crossref","unstructured":"Rogers, L., Barani, I., Chamberlain, M., et al. 2015. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. Journal of Neurosurgery 122(1), pp. 4\u201323.","DOI":"10.3171\/2014.7.JNS131644"},{"key":"10_CR87","doi-asserted-by":"crossref","unstructured":"Sahm, F., Schrimpf, D., Olar, A., et al. 2016. TERT promoter mutations and risk of recurrence in meningioma. Journal of the National Cancer Institute 108(5).","DOI":"10.1093\/jnci\/djv377"},{"issue":"5","key":"10_CR88","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","volume":"18","author":"F Sahm","year":"2017","unstructured":"Sahm, F., Schrimpf, D., Stichel, D., et al. 2017. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. The Lancet Oncology 18(5), pp. 682\u2013694.","journal-title":"The Lancet Oncology"},{"issue":"Suppl 7","key":"10_CR89","doi-asserted-by":"publisher","first-page":"S882","DOI":"10.21037\/jtd.2018.03.81","volume":"10","author":"M Santarpia","year":"2018","unstructured":"Santarpia, M., Liguori, A., D\u2019Aveni, A., et al. 2018. Liquid biopsy for lung cancer early detection. Journal of thoracic disease 10(Suppl 7), pp. S882\u2013S897.","journal-title":"Journal of thoracic disease"},{"issue":"7732","key":"10_CR90","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41586-018-0703-0","volume":"563","author":"SY Shen","year":"2018","unstructured":"Shen, S.Y., Singhania, R., Fehringer, G., et al. 2018. Sensitive tumour detection and classification using plasma cell-free DNA methylomes. Nature 563(7732), pp. 579\u2013583.","journal-title":"Nature"},{"issue":"1","key":"10_CR91","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","volume":"20","author":"D Simpson","year":"1957","unstructured":"Simpson, D. 1957. The recurrence of intracranial meningiomas after surgical treatment. Journal of Neurology, Neurosurgery, and Psychiatry 20(1), pp. 22\u201339.","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"2","key":"10_CR92","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s10014-019-00337-y","volume":"36","author":"Y Sonoda","year":"2019","unstructured":"Sonoda, Y., Yokoo, H., Tanaka, S., et al. 2019. Practical procedures for the integrated diagnosis of astrocytic and oligodendroglial tumors. Brain tumor pathology 36(2), pp. 56\u201362.","journal-title":"Brain tumor pathology"},{"key":"10_CR93","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.wneu.2016.06.055","volume":"93","author":"DC Spille","year":"2016","unstructured":"Spille, D.C., He\u00df, K., Sauerland, C., et al. 2016. Brain Invasion in Meningiomas: Incidence and Correlations with Clinical Variables and Prognosis. World neurosurgery 93, pp. 346\u2013354.","journal-title":"World neurosurgery"},{"key":"10_CR94","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.wneu.2019.05.017","volume":"128","author":"DC Spille","year":"2019","unstructured":"Spille, D.C., Sporns, P.B., He\u00df, K., Stummer, W. and Brokinkel, B. 2019. Prediction of High-Grade Histology and Recurrence in Meningiomas Using Routine Preoperative Magnetic Resonance Imaging: A Systematic Review. World neurosurgery 128, pp. 174\u2013181.","journal-title":"World neurosurgery"},{"issue":"2","key":"10_CR95","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3171\/2016.8.JNS161076","volume":"127","author":"MR Strickland","year":"2017","unstructured":"Strickland, M.R., Gill, C.M., Nayyar, N., et al. 2017. Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas. Journal of Neurosurgery 127(2), pp. 438\u2013444.","journal-title":"Journal of Neurosurgery"},{"issue":"Suppl 1","key":"10_CR96","doi-asserted-by":"publisher","first-page":"i4","DOI":"10.1093\/neuonc\/noy178","volume":"21","author":"S Suppiah","year":"2019","unstructured":"Suppiah, S., Nassiri, F., Bi, W.L., et al. 2019. Molecular and translational advances in meningiomas. Neuro-oncology 21(Suppl 1), pp. i4\u2013i17.","journal-title":"Neuro-oncology"},{"issue":"3\u20134","key":"10_CR97","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0090-3019(02)00831-5","volume":"58","author":"P Tagle","year":"2002","unstructured":"Tagle, P., Villanueva, P., Torrealba, G. and Huete, I. 2002. Intracranial metastasis or meningioma? Surgical Neurology 58(3\u20134), pp. 241\u2013245.","journal-title":"Surgical Neurology"},{"issue":"2","key":"10_CR98","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ijrobp.2009.11.032","volume":"79","author":"E Tanzler","year":"2011","unstructured":"Tanzler, E., Morris, C.G., Kirwan, J.M., Amdur, R.J. and Mendenhall, W.M. 2011. Outcomes of WHO Grade I meningiomas receiving definitive or postoperative radiotherapy. International Journal of Radiation Oncology, Biology, Physics 79(2), pp. 508\u2013513.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"4","key":"10_CR99","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00401-011-0922-z","volume":"123","author":"MD Taylor","year":"2012","unstructured":"Taylor, M.D., Northcott, P.A., Korshunov, A., et al. 2012. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathologica 123(4), pp. 465\u2013472.","journal-title":"Acta Neuropathologica"},{"issue":"1","key":"10_CR100","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/jnen\/nlv006","volume":"75","author":"RA Vaubel","year":"2016","unstructured":"Vaubel, R.A., Chen, S.G., Raleigh, D.R., et al. 2016. Meningiomas with rhabdoid features lacking other histologic features of malignancy: A study of 44 cases and review of the literature. Journal of Neuropathology and Experimental Neurology 75(1), pp. 44\u201352.","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"4","key":"10_CR101","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3171\/2013.7.JNS13311","volume":"119","author":"J Vengoechea","year":"2013","unstructured":"Vengoechea, J., Sloan, A.E., Chen, Y., et al. 2013. Methylation markers of malignant potential in meningiomas. Journal of Neurosurgery 119(4), pp. 899\u2013906.","journal-title":"Journal of Neurosurgery"},{"issue":"6","key":"10_CR102","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1097\/WCO.0000000000000615","volume":"31","author":"VA Venur","year":"2018","unstructured":"Venur, V.A., Santagata, S., Galanis, E. and Brastianos, P.K. 2018. New molecular targets in meningiomas: the present and the future. Current Opinion in Neurology 31(6), pp. 740\u2013746.","journal-title":"Current Opinion in Neurology"},{"issue":"3","key":"10_CR103","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10014-015-0221-9","volume":"32","author":"M Venza","year":"2015","unstructured":"Venza, M., Visalli, M., Beninati, C., et al. 2015. Involvement of epimutations in meningioma. Brain tumor pathology 32(3), pp. 163\u2013168.","journal-title":"Brain tumor pathology"},{"issue":"1","key":"10_CR104","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RGW Verhaak","year":"2010","unstructured":"Verhaak, R.G.W., Hoadley, K.A., Purdom, E., et al. 2010. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1), pp. 98\u2013110.","journal-title":"Cancer Cell"},{"issue":"1","key":"10_CR105","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s40478-019-0690-x","volume":"7","author":"AN Viaene","year":"2019","unstructured":"Viaene, A.N., Zhang, B., Martinez-Lage, M., et al. 2019. Transcriptome signatures associated with meningioma progression. Acta neuropathologica communications 7(1), p. 67.","journal-title":"Acta neuropathologica communications"},{"key":"10_CR106","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/B978-0-12-804280-9.00012-3","volume":"169","author":"JE Villanueva-Meyer","year":"2020","unstructured":"Villanueva-Meyer, J.E. 2020. Modern day imaging of meningiomas. Handbook of Clinical Neurology 169, pp. 177\u2013191.","journal-title":"Handbook of Clinical Neurology"},{"issue":"1","key":"10_CR107","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jmoldx.2016.08.007","volume":"19","author":"J Wang","year":"2017","unstructured":"Wang, J. and Bettegowda, C. 2017. Applications of DNA-Based Liquid Biopsy for Central Nervous System Neoplasms. The Journal of Molecular Diagnostics 19(1), pp. 24\u201334.","journal-title":"The Journal of Molecular Diagnostics"},{"key":"10_CR108","unstructured":"Youngblood, M.W., Duran, D., Montejo, J.D., et al. 2019. Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas. Journal of Neurosurgery, pp. 1\u201310."},{"issue":"12","key":"10_CR109","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s00234-019-02259-0","volume":"61","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y., Chen, J.-H., Chen, T.-Y., et al. 2019. Radiomics approach for prediction of recurrence in skull base meningiomas. Neuroradiology 61(12), pp. 1355\u20131364.","journal-title":"Neuroradiology"},{"key":"10_CR110","doi-asserted-by":"publisher","unstructured":"Sievers, P., Hielscher, T., Schrimpf, D., Stichel, D., Reuss, D.E., Berghoff, A.S., Neidert, M.C., Wirsching, H.G., Mawrin, C., Ketter, R., Paulus, W., Reifenberger, G., Lamszus, K., Westphal, M., Etminan, N., Ratliff, M., Herold-Mende, C., Pfister, S.M., Jones, D.T.W., Weller, M., Harter, P.N., Wick, W., Preusser, M., von Deimling, A., Sahm, F. 2020. CDKN2A\/B homozygous deletion is associated with early recurrence in meningiomas. Acta Neuropathol 140(3), pp. 409\u2013413. https:\/\/doi.org\/10.1007\/s00401-020-02188-w. Epub 2020 Jul 8. PMID: 32642869; PMCID: PMC7423850..","DOI":"10.1007\/s00401-020-02188-w"},{"key":"10_CR111","doi-asserted-by":"publisher","unstructured":"Biczok, A., Kraus, T., Suchorska, B., Terpolilli, N.A., Thorsteinsdottir, J., Giese, A., Tonn, J.C., Schichor, C. 2018. TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas. J Neurooncol 139(3), pp. 671\u2013678. https:\/\/doi.org\/10.1007\/s11060-018-2912-7. Epub 2018 May 28. PMID: 29808339.","DOI":"10.1007\/s11060-018-2912-7"}],"container-title":["Advances in Experimental Medicine and Biology","Biological and Clinical Landscape of Meningiomas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-29750-2_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T09:04:27Z","timestamp":1689066267000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-29750-2_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9783031297496","9783031297502"],"references-count":111,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-29750-2_10","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"12 July 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}